Sleep Quality Improvement Enhances Neuropsychological Recovery and Reduces Blood Aβ(42/40) Ratio in Patients with Mild–Moderate Cognitive Impairment

Background and objectives: Alzheimer’s disease is a progressive brain degeneration and is associated with a high prevalence of sleep disorders. Amyloid β peptide-42/40 (Aβ(42/40)) and Tau-pT181 are the core biomarkers in cerebrospinal fluid and blood. Accumulated data from studies in mouse models an...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Haihua, Li, Mingqiu, Zhang, Menglin, Qiu, Jiang, Cheng, Haiyan, Mou, Xin, Chen, Qinghong, Li, Tina, Peng, Jun, Li, Benyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8704453/
https://www.ncbi.nlm.nih.gov/pubmed/34946311
http://dx.doi.org/10.3390/medicina57121366

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8704453/
https://www.ncbi.nlm.nih.gov/pubmed/34946311
http://dx.doi.org/10.3390/medicina57121366

Ejemplares similares